Maurine Ng’oda
A5024408874- SARS-CoV-2 and COVID-19 Research
- Vaccine Coverage and Hesitancy
- COVID-19 epidemiological studies
- Mentoring and Academic Development
- Health Systems, Economic Evaluations, Quality of Life
- Immune responses and vaccinations
- COVID-19 Clinical Research Studies
- Diversity and Career in Medicine
- Global Public Health Policies and Epidemiology
- Diabetes Management and Education
- Chronic Disease Management Strategies
- Viral Infections and Outbreaks Research
- Healthcare Systems and Reforms
- Perfectionism, Procrastination, Anxiety Studies
- Global Maternal and Child Health
- Virology and Viral Diseases
African Population and Health Research Center
2022-2024
We sought to estimate SARS-CoV-2 antibody seroprevalence within representative samples of the Kenyan population during third year COVID-19 pandemic and second vaccine use.
Most of the studies that have informed public health response to COVID-19 pandemic in Kenya relied on samples are not representative general population. We conducted population-based serosurveys at three Health and Demographic Surveillance Systems (HDSSs) determine cumulative incidence infection with SARS-CoV-2.
Abstract Background Up-to-date SARS-CoV-2 antibody seroprevalence estimates are important for informing public health planning, including priorities Coronavirus disease 2019 (COVID-19) vaccination programs. We sought to estimate infection- and vaccination-induced within representative samples of the Kenyan population approximately two years into COVID-19 pandemic one year after rollout national program. Methods conducted cross-sectional serosurveys random, age-stratified Kilifi Health...
ABSTRACT Background Most of the studies that have informed public health response to COVID-19 pandemic in Kenya relied on samples are not representative general population. We conducted population-based serosurveys at three Health and Demographic Surveillance Systems (HDSSs) determine cumulative incidence infection with SARS-CoV-2. Methods selected random age-stratified HDSSs Kisumu, Nairobi Kilifi, Kenya. Blood were collected from participants between 01 Dec 2020 27 May 2021. No participant...
ABSTRACT Completion of vaccine doses is essential for robust immunity and long-term protection against specific diseases. This study aimed to investigate factors associated with the completion multi-dose COVID-19 vaccines (MDV) among adolescents adults in two informal urban settlements Nairobi, Kenya. We analyzed data from Kenya Multisite Integrated Serosurveillance (KEMIS) project. defined MDV as receiving an additional dose between weeks 6 8 following first vaccination shot. applied...